Editorial standards and evidence review
Our commitments
- Plain language first, with an optional section for researchers and clinicians.
- A source on every drug, trial and numeric claim, linked so you can read it yourself.
- Dated evidence reviews, shown on every medical page.
- No doses, no treatment recommendations, no "start or stop" instructions, and no cure claims.
Where our information comes from
- Clinical practice guidelines: KDIGO, EULAR, the British Society for Rheumatology, the American College of Rheumatology and transplant societies.
- Regulators: the U.S. FDA and the European Medicines Agency.
- Government health agencies: the NIH and NIDDK, CMS and HRSA.
- Trial registries (ClinicalTrials.gov and the EU Clinical Trials Information System) and peer-reviewed journals.
- Established patient organizations such as the Vasculitis Foundation, the National Kidney Foundation and the American Kidney Fund.
Company press releases are labeled "company-reported", and conference abstracts are labeled as abstracts. We never invent citations, trial results or numbers. Study figures are described as results "in this study", because they cannot predict what will happen to any one person.
How pages are written
- The content is based on a detailed, referenced patient guide on MPA and kidney disease (evidence reviewed 15 November 2026). We rewrite it in plain language and check each claim against its source.
- Examples are general. The site contains no personal health information about anyone.
- Writing is AI-assisted and edited by Projects & Guides.
What "Evidence reviewed Nov 2026" means
In November 2026 we checked every source cited on that page, confirmed the link works, and checked the claim against it. Research and regulatory items also show their own "last checked" date.
Latest research rules
Each research item shows an evidence badge (Approved, Phase 3, Phase 2, Early trial, Case report, Preclinical/lab/computational, plus a red Safety or regulatory alert badge), a "last checked" date, and links to the primary record. Hope is welcome; hype is not. See the research hub.
Update policy
- Stable pages are re-reviewed at least every 12 months.
- Research and regulatory pages (such as avacopan) are re-checked at least monthly and whenever major news breaks.
- Material changes are recorded in the changelog on the sources page.
Independence
This site has no ads, no affiliate links and no sponsors, and it sells nothing. No drug company or organization has paid for content.
Corrections
We welcome corrections from patients, families, clinicians and researchers, and we fix verified errors promptly.